Journal
NATURE BIOTECHNOLOGY
Volume 34, Issue 10, Pages 1066-1071Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.3663
Keywords
-
Categories
Funding
- NIH
- NIGMS [RO1 GM57226, RO1 GM098446, RO1GM089807]
- NIAID [R01029690]
- Canadian Institutes for Health Research [FRN 119339]
- Knut and Alice Wallenberg's Foundation [2014.0212]
- Swedish Heart-Lung Foundation [20150767]
- Svenska Lakaresallskapet
- [VR 2013-3003]
Ask authors/readers for more resources
Blood pressure regulation is known to be maintained by a neuro-endocrine circuit, but whether immune cells contribute to blood pressure homeostasis has not been determined. We previously showed that CD4(+) T lymphocytes that express choline acetyltransferase (ChAT), which catalyzes the synthesis of the vasorelaxant acetylcholine, relay neural signals(1). Here we show that these CD4(+)CD44(hi)CD62L(Io) T helper cells by gene expression are a distinct T-cell population defined by ChAT (CD4 T-ChAT). Mice lacking ChAT expression in CD4(+) cells have elevated arterial blood pressure, compared to littermate controls. Jurkat T cells overexpressing ChAT (JT(ChAT)) decreased blood pressure when infused into mice. Co-incubation of JT(ChAT) and endothelial cells increased endothelial cell levels of phosphorylated endothelial nitric oxide synthase, and of nitrates and nitrites in conditioned media, indicating increased release of the potent vasorelaxant nitric oxide. The isolation and characterization of CD4 T-ChAT cells will enable analysis of the role of these cells in hypotension and hypertension, and may suggest novel therapeutic strategies by targeting cell-mediated vasorelaxation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available